Skip to main content
. 2018 Jun 21;3(12):e99976. doi: 10.1172/jci.insight.99976

Figure 2. High AZIN1 RNA editing levels and high expression of ADAR1 correlate with poor prognosis of OS and DFS in the clinical evaluation cohort.

Figure 2

(A) TNM stage-dependent expression status of ADAR1 and AZIN1 RNA editing levels in CRC tissues (Kruskal-Wallis test). (B) Kaplan-Meier survival curves for OS in CRC patients in the clinical evaluation cohort (n = 220) sorted into low and high expression levels of ADAR1 and low and high AZIN1 RNA editing status (log-rank test). (C) Kaplan-Meier survival curves for DFS in CRC patients in the clinical evaluation cohort (n = 220) were sorted into low and high expression levels of ADAR1 and low and high AZIN1 RNA editing status (log-rank test).